期刊文献+

uPAR促进恶性脑膜瘤细胞的侵袭 被引量:2

uPAR promotes malignant meningioma cells invasion
下载PDF
导出
摘要 目的探索脑膜瘤中尿激酶型纤溶酶原激活物(uPA)及其受体(uPAR)表达水平与病理等级间关系;探索uPAR在恶性脑膜瘤中的功能及其机制。方法通过检测各等级脑膜瘤临床标本中uPAR和uPA表达水平,分析其表达量与病理等级间关系。通过体外实验干扰uPAR表达,观察恶性脑膜瘤细胞侵袭能力的变化,并检测细胞中侵袭相关因子MMP2、MMP9及E-cadherin的表达变化。结果临床标本中脑膜瘤病理等级越高uPAR和uPA的蛋白表达量也越高:在Ⅰ级脑膜瘤组织中均以弱阳性表达为主(uPA占73.30%,uPAR占66.66%);Ⅱ级脑膜瘤组织中均呈弱阳性(uPA占37.50%,uPAR占18.75%)、中阳性(uPA占37.50%,uPAR占43.75%)、强阳性(uPA占25.00%,uPAR占37.50%)均衡表达;Ⅲ级脑膜瘤组织中均以强阳性(uPA占66.6%,uPAR占83.33%)表达为主。干扰uPAR表达后,脑膜瘤细胞侵袭能力明显降低,细胞中侵袭相关因子MMP2、MMP9的蛋白表达也明显降低。结论 uPA-uPAR表达在脑膜瘤中,其表达量与脑膜瘤的恶性等级成正相关;uPAR对恶性脑膜瘤细胞有促侵袭功能,该功能可能通过调控MMP2和MMP9的表达来实现的。 Objective To explore the relationships among tumor grade and levels of urokinase-type plasminogen activator(uPA) or its receptor(uPAR) in meningiomas.The function of uPAR and its molecular mechanisms in malignant meningiomas were also studied .Methods We detected the protein levels of uPAR and uPA in 58 samples of meningiomas to analyze whether the protein levels of uPAR/uPA were related to tumor grade of meningiomas .The expression of uPAR to study whether uPAR affects the invasion of malignant meningioma cells and the expression levels of invasive molecules ( MMP-2 , MMP-9 and E-cadherin ) were knocked down .Results The protein levels of uPAR and uPA was proportional to malignant degree of meningiomas .In normal brain tissues ,uPAR and uPA were not detected , in grade Ⅰ meningiomas , uPAR and uPA were mainly weekly stained ( week:uPA 73 .30%, uPAR 66 .66%) .In grade Ⅱ meningiomas , uPAR and uPA were equably stained in each grade meningiomas ( week:uPA 37.50%,uPAR 18.75%,moderate:uPA 37.50%, uPAR 43.75%;strong:uPA 25.00%,uPAR 37.50%).In grade Ⅲ meningiomas,uPAR and uPA were mainly strongly stained ( strong:uPA 66.6%,uPAR 83.33%).Knockdown of uPAR did not affect the expression of uPA , but strongly decreased the levels of MMP-2 and MMP-9 .Knockdown of uPAR also decreased the invasion of malignant meningioma cells .Conclusion The uPA-uPAR system was extensively expressed in meningiomas , and its expression level was proportional to malignant degree of meningiomas .uPAR shows ability to increase the invasion of malignant meningioma cell by regulating MMP2 and MMP9.
出处 《临床神经外科杂志》 CAS 2014年第5期335-338,343,共5页 Journal of Clinical Neurosurgery
  • 相关文献

参考文献12

  • 1张东智,杨光,韩大勇,刘耀华,赵世光.脑膜瘤分子机制研究进展[J].临床神经外科杂志,2013,10(5):318-320. 被引量:5
  • 2胡新华,刘宏毅,邹元杰,张锐,彭永森.恶性脑膜瘤的影像学特点和显微手术治疗[J].临床神经外科杂志,2005,2(2):86-87. 被引量:10
  • 3Bass R, Ellis V. Regulation of urokinase receptor function and peficellular proteolysis by the integrin alpha ( 5 ) beta ( 1 ) [ J ]. Thromb Haemost ,2009,101:954.
  • 4Rao JS. Molecular mechanisms of glioma invasiveness: the role of proteases [ J ]. Nat Rev Cancer,2003,3:489.
  • 5de Robles P, Mcintyre J, Kalra S, et al. Methylation status of MGMT gene promoter in meningiomas [ J ]. Cancer Genet Cytogenet ,2008,187:25.
  • 6Hanft S,Canoll P, Bruce JN. A review of malignant meningiomas: diagnosis, characteristics and treatment [ J ]. J Neurooncol, 2010, 99:433.
  • 7Karl.otis O ,Chetty C ,Go$ineni V ,et al. uPA/uPAR downr%mlation inhibits radiation-induced migration, inwaion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo [J]. Int J Oncol,2008,33:937.
  • 8Wen PY, Quant E, Drappatz J, et al. Medical therapies for meningiomas[ J]. J Neurooncol,2010,99:365.
  • 9Blasi F, CamMiet P. uPAR : a versatile signalling orchestrator[ J ]. Nat Rev Mol Cell Biol,2002,3:932.
  • 10Mandriota SJ, Seghezzi G, Vassalli J D, et al. Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells[ J]. J Biol Chem, 1995,270:9709.

二级参考文献31

  • 1黄思庆.恶性脑膜瘤的诊断与治疗[J].华西医学,1995,10(1):93-94. 被引量:6
  • 2Perry A,Louis DN,Scheithauer BW,Budka H,el at.World Health Organization Classification of Tumours of the Central Nervous System[M].4th ed Lyon:IARC,2007:164.
  • 3Vernooij MW,Ikram MA,Tanghe HL,et al.Incidental findings on brain MRI in the general population[J].N Engl J Med,2007,357:1821.
  • 4Perry A,Scheithauer BW,Stafford SL,et al."Malignancy" in meningiomas:a clinicopathologic study of 116 patients,with grading implications[J].Cancer,1999,85:2046.
  • 5Campbell BA,Jhamb A,Maguire JA,et al.Meningiomas in 2009:controversies and future challenges[J].Am J Clin Oncol,2009,32:73.
  • 6Zang KD.Meningioma:a cytogenetic model of a complex benign human tumor,including data on 394 karyotyped cases[J].Cytogenet Cell Genet,2001,93:207.
  • 7Drummond KJ,Zhu JJ,Black PM.Meningiomas:updating basic science,management,and outcome[J].Neurologist,2004,10:113.
  • 8Hartmann C,Sieberns J,Gehlhaar C,et al.NF2 mutations in secretory and other rare variants of meningiomas[J].Brain Pathol,2006,16:15.
  • 9Wong HK,Shimizu A,Kirkpatrick ND,et al.Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphoring 3F-dependent mechanism[J].Neoolasia,2012,14:84.
  • 10Gerber MA,Bahr SM,Gutmann DH.Protein 4.1B/differentially expressed in adenocarcinoma of the lung-1 functions as a growth suppressor in meningioma cells by activating Rac1-dependent cJun-NH (2)-kinase signaling[J].Cancer Res,2006,66:5295.

共引文献12

同被引文献22

  • 1曹慧芳,史浩,丁红宇.颅内血管外皮细胞瘤的CT和MRI诊断[J].医学影像学杂志,2005,15(5):361-363. 被引量:4
  • 2Reid H. Tumours of the nervous system : Paul Kleihues and Webster K Cavenee [ J ]. Surgical Oncology ,2000,9:205.
  • 3Simpson D. The recurrence of intracranial meningiomas after surgical treatment [ J ]. J Neurology Neurosurgery Psychiatry, 1957, 20:22.
  • 4Detti B ,Scoccianti S, Di Cataldo VD ,et al. Atypical and malignant meningioma: outcome and prognostic factors in 68 irradiated patients[ J]. J Neuro-Oncology, 2013, 115:421.
  • 5Pasquier D, Bijmolt S, Veninga T, et al, Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network[J]. Int J Radiat Oncol Biol Phys, 2008, 71:1388.
  • 6Bruna J, Brell M, Ferrer I, et al. Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastie meningioma [ J]. Neuropathology,2007,27 : 114.
  • 7Dziuk TW, Woo S, Butler EB, et al. Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy [ J]. J Neuro-Oncology, 1998,37 : 177.
  • 8Ko KW, Nam DH, Kong DS, et al. Relationship between malignant subtypes of meningioma and clinical outcome [ J ]. J Clinical Neuroscience ,2007,14:747.
  • 9Palma L,Celli P,Franco C,et al. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases [ J]. J Neurosurg, 1997,86:793.
  • 10Rosenberg L, Prayson R, Lee J, et al. Long-term experience with World Health Organization grade Ⅲ(malignant) meningiomas at a single institution [ J ]. Int J Radiat Oncol Biol Phys,2009,74:427.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部